An economic analysis of different treatments for bleeding in patients with acquired haemophilia
Sign Up to like & getrecommendations! Published in 2019 at "Vox Sanguinis"
DOI: 10.1111/vox.12877
Abstract: Acquired haemophilia A (AHA), with potentially high risk of morbidity and mortality, occurs as a result of inhibitors against factor VIII. Bleeding due to AHA can be treated with activated prothrombin complex concentrate (aPCC), recombinant… read more here.
Keywords: acquired haemophilia; economic analysis; analysis; treatments bleeding ... See more keywords